RARE-25. RETINAL ASTROCYTOMA mTOR INHIBITOR THERAPY IN TUBEROUS SCLEROSIS MOSAICISM

INTRODUCTION: Everolimus is an inhibitor of mTORC1 (mammalian target of rapamycin complex 1), it is Health Canada and FDA approved for SEGA and renal angiomyolipoma in the setting of tuberous sclerosis complex (TSC). There is little data available in regards to this treatment of TSC associated retin...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Evans, Naomi, Paton, Katherine, Gill, Harinder Kaur, Hukin, Juliette
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Craniopharyngioma and Rare Tumors
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715490/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.736
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items